Uterine Fibroid Embolization (sometimes called Uterine Artery Embolization)
Specialists in uterine fibroid embolization in Memphis, TN.
What is Uterine Fibroid Embolization?
Uterine Fibroid Embolization (UFE) is a new, minimally invasive procedure
that helps shrink uterine fibroids
without surgery. UFE is performed by interventional radiologists, who
are board-certified, medically trained physicians who specialize in performing
minimally invasive, targeted treatments. Using a tiny catheter, the interventional
radiologist’s blocks the blood supply to the fibroids by placing the catheter
into the artery through the groin. Using X-ray imaging, radiologists direct
the tip of the catheter into the main artery supplying blood to the uterus.
Small plastic particles, which are about the size of grains of sand, are
placed in that artery, blocking blood flow to the fibroid. The fibroid
shrinks or dies completely from lack of blood flow. UFE is performed while
patients are conscious and sedated.
What are the Advantages of UFE?
Uterine Fibroid Embolization is considered to be very safe and is about 90 percent effective
in relieving or eliminating the symptoms of uterine fibroids. The procedure
has even been successful in treating women with multiple uterine fibroid
tumors. Usually, patients only stay in the hospital for 24 hours, and
most patients fully recover within 10 days. Most importantly as a hysterectomy
alternative for many women, UFE leaves all reproductive organs intact
and may preserve patients’ ability to have children.
Have there been any studies showing the success of UFE?
According to study findings presented at the 2006 annual scientific
meeting of the Society of Interventional Radiology (SIR), uterine artery
embolization (UAE) is an effective treatment for uterine fibroids that
is safer than surgery and is also associated with shorter hospital stays.
The British Journal of Obstetrics and Gynecology published the largest
UFE study to date, which found the procedure had a high success rate,
low symptom recurrence rate, and no regrowth of treated fibroids. Ninety-seven
percent of the 400 women studies were pleased with the outcome and would
recommend the treatment to others, and 84 percent showed an improvement
in symptoms. The results are similar to and confirm the results of another
study reported in Obstetrics and Gynecology. That study reported an improvement
of symptoms in 90 percent of patients.
Uterine leiomyomas (fibroid tumors) are the most common tumors in the female reproductive tract; they occur in 20-40% of women over the age of 35. Fibroids are benign tumors responsive to estrogen and increase in size and number with age and tend to regress after menopause.
Minimally invasive procedure for uterine artery embolization – Memphis, TN